Gestonorone caproate
http://dbpedia.org/resource/Gestonorone_caproate an entity of type: Thing
Gestonorone caproate, also known as gestronol hexanoate or norhydroxyprogesterone caproate and sold under the brand names Depostat and Primostat, is a progestin medication which is used in the treatment of enlarged prostate and cancer of the endometrium. It is given by injection into muscle typically once a week.
rdf:langString
rdf:langString
Gestonorone caproate
xsd:integer
6659682
xsd:integer
1099102142
rdf:langString
DA01
rdf:langString
G03
rdf:langString
: High
rdf:langString
Oral: Low
xsd:integer
26
xsd:integer
1253
xsd:integer
31650
xsd:integer
2107389
xsd:integer
391969
rdf:langString
DB14677
<second>
267840.0
rdf:langString
Feces: 72%
rdf:langString
Urine: 28%
xsd:integer
38
rdf:langString
Gestonorone caproate molecule ball.png
rdf:langString
[-17-acetyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] hexanoate
rdf:langString
D01159
rdf:langString
Rx-only
xsd:integer
4
xsd:integer
443881
rdf:langString
CCCCCCOC1CC
xsd:integer
1
rdf:langString
XURCMZMFZXXQDJ-UKNJCJGYSA-N
rdf:langString
Gestronol hexanoate; Norhydroxyprogesterone caproate; SH-582; SH-80582; NSC-84054; 17α-Hydroxy-19-norpregn-4-ene-3,20-dione hexanoate; 17α-Hydroxy-19-norprogesterone hexanoate
rdf:langString
Depostat, Primostat
rdf:langString
U38E620NS6
xsd:integer
250
rdf:langString
Gestonorone caproate, also known as gestronol hexanoate or norhydroxyprogesterone caproate and sold under the brand names Depostat and Primostat, is a progestin medication which is used in the treatment of enlarged prostate and cancer of the endometrium. It is given by injection into muscle typically once a week. Side effects of gestonorone caproate include worsened glucose tolerance, decreased libido in men, and injection site reactions. Gestonorone caproate is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone. It has no other important hormonal activity. Gestonorone caproate was discovered in 1960 and was introduced for medical use by 1973. It has been used widely throughout Europe, including in the United Kingdom, and has also been marketed in certain other countries such as Japan, China, and Mexico. However, it has since mostly been discontinued, and it remains available today only in a handful of countries, including the Czech Republic, Japan, Mexico, and Russia.
<second>
1814400.0
rdf:langString
• 19-Norpregnanetriol
xsd:nonNegativeInteger
41069
rdf:langString
Depostat, Primostat
xsd:string
1253-28-7
xsd:string
31650
xsd:string
2107389
xsd:string
DB14677
xsd:string
U38E620NS6
xsd:string
D01159
xsd:string
443881
